ARTICLE | Clinical News
Aerius regulatory update
October 26, 2015 7:00 AM UTC
Merck submitted an NDA in Japan for desloratadine to treat allergic rhinitis, hives and itching resulting from skin diseases. Merck markets the histamine H1 receptor (HRH1) antagonist as Clarinex in ...